Not logged inHER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01
Siena, Salvatore; Raghav, Kanwal; Masuishi, Toshiki; Yamaguchi, Kensei; Nishina, Tomohiro; Elez, Elena; Rodriguez, Javier; Chau, Ian; Di Bartolomeo, Maria; Kawakami, Hisato; Suto, Fumitaka; Koga, Makito; Inaki, Koichiro; Kuwahara, Yusuke; Takehara, Issey; Barrios, Daniel; Kobayashi, Kojiro; Grothey, Axel; Yoshino, Takayuki .png)
Share.png)
SaveEvaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database (vol 178, pg 162, 2023)Margalit, Ofer; Harmsen, William S.; Shacham-Shmueli, Einat; Voss, Molly M.; Boursi, Ben; Wagner, Anna D.; Cohen, Romain; Olswold, Curtis L.; Saltz, Leonard B.; Goldstein, Daniel A.; Hurwitz, Herbert; Tebbutt, Niall C.; Kabbinavar, Fairooz F.; Adams, Richard A.; Chibaudel, Benoist; Grothey, Axel; Yoshino, Takayuki; Zalcberg, John; de Gramont, Aimery; Shi, Qian; Lenz, Heinz-Josef Share Save Share Save Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancerDucreux, Michel; Tabernero, Josep; Grothey, Axel; Arnold, Dirk; O'Dwyer, Peter J.; Gilberg, Frank; Abbas, Alexander; Das Thakur, Meghna; Prizant, Hen; Irahara, Natsumi; Tahiri, Anila; Schmoll, Hans -Joachim; Van Cutsem, Eric; de Gramont, Aimery Share Save Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C StudyShah, Manish A.; Yoshino, Takayuki; Tebbutt, Niall C.; Grothey, Axel; Tabernero, Josep; Xu, Rui-Hua; Cervantes, Andres; Oh, Sang Cheul; Yamaguchi, Kensei; Fakih, Marwan; Falcone, Alfredo; Wu, Christina; Chiu, Vi K.; Tomasek, Jiri; Bendell, Johanna; Fontaine, Marilyn; Hitron, Matthew; Xu, Bo; Taieb, Julien; Van Cutsem, Eric Share Save Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD databaseMargalit, Ofer; Harmsen, William S.; Shacham-Shmueli, Einat; Voss, Molly M.; Boursi, Ben; Wagner, Anna D.; Cohen, Romain; Olswold, Curtis L.; Saltz, Leonard B.; Goldstein, Daniel A.; Hurwitz, Herbert; Tebbutt, Niall C.; Kabbinavar, Fairooz F.; Adams, Richard A.; Chibaudel, Benoist; Grothey, Axel; Yoshino, Takayuki; Zalcberg, John; de Gramont, Aimery; Shi, Qian; Lenz, Heinz-Josef Share Save MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAFwt metastatic colorectal cancerTabernero, J.; Grothey, A.; Arnold, D.; de Gramont, A.; Ducreux, M.; O'Dwyer, P.; Tahiri, A.; Gilberg, F.; Irahara, N.; Schmoll, H-J; Van Cutsem, E. Share Save Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRCKopetz, S.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H.; Yoshino, T.; Desai, J.; Ciardiello, F.; Loupakis, F.; Hong, Y. S.; Steeghs, N.; Guren, T. K.; Arkenau, H-T; Garcia-Alfonso, P.; Belani, A.; Zhang, X.; Tabernero, J. Share Save Share Save Evaluating sex as a predictive marker for response to bevacizuamb in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD databaseMargalit, O.; Harmsen, W.; Shacham-Shmueli, E.; Voss, M.; Boursi, B.; Cohen, R.; Olswold, C.; Saltz, L.; Hurwitz, H.; Adams, R.; Chibaudel, B.; Grothey, A.; Yoshino, T.; Zalcberg, J.; de Gramont, A.; Shi, Q.; Lenz, H. Share Save Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer=70 yearsPapamichael, Demetris; Lopes, Guilherme S.; Olswold, Curt L.; Douillard, Jean-Yves; Adams, Richard A.; Maughan, Timothy S.; Van Cutsem, Eric; Venook, Alan P.; Lenz, Heinz-Josef; Heinemann, Volker; Kaplan, Richard; Bokemeyer, Carsten; Chibaudel, Benoist; Grothey, Axel; Yoshino, Takayuki; Zalcberg, John; De Gramont, Aimery; Shi, Qian Share Save Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First-and Second-Line Clinical TrialsMcCleary, Nadine J.; Harmsen, William S.; Haakenstad, Ellana; Cleary, James M.; Meyerhardt, Jeffrey A.; Zalcberg, John; Adams, Richard; Grothey, Axel; Sobrero, Alberto F.; Van Cutsem, Eric; Goldberg, Richard M.; Peeters, Marc; Tabernero, Josep; Seymour, Matt; Saltz, Leonard B.; Giantonio, Bruce J.; Arnold, Dirk; Rothenberg, Mace L.; Koopman, Miriam; Schmoll, Hans-Joachim; Pitot, Henry C.; Hoff, Paulo M.; Tebbutt, Niall; Masi, Gianluca; Souglakos, John; Bokemeyer, Carsten; Heinemann, Volker; Yoshino, Takayuki; Chibaudel, Benoist; deGramont, Aimery; Shi, Qian; Lichtman, Stuart M. Share Save Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials MethodologyGoldberg, Richard M.; Adams, Richard; Buyse, Marc; Eng, Cathy; Grothey, Axel; Andre, Thierry; Sobrero, Alberto F.; Lichtman, Stuart M.; Benson, Al B.; Punt, Cornelis J. A.; Maughan, Tim; Burzykowski, Tomasz; Sommeijer, Dirkje; Saad, Everardo D.; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, Miriam; Schmoll, Hans-Joachim; Yoshino, Takayuki; Taieb, Julien; Tebbutt, Niall C.; Zalcberg, John; Tabernero, Josep; Van Cutsem, Eric; Matheson, Alastair; de Gramont, Aimery Share Save Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC studyTabernero, J.; Velez, L.; Trevino, T. L.; Grothey, A.; Yaeger, R.; Van Cutsem, E.; Wasan, H.; Desai, J.; Ciardiello, F.; Yoshino, T.; Gollerkeri, A.; Maharry, K.; Christy-Bittel, J.; Kopetz, S. Share Save Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelinesBonney, Glenn K.; Chew, Claire Alexandra; Lodge, Peter; Hubbard, Joleen; Halazun, Karim J.; Trunecka, Pavel; Muiesan, Paolo; Mirza, Darius F.; Isaac, John; Laing, Richard W.; Iyer, Shridhar Ganpathi; Chee, Cheng Ean; Yong, Wei Peng; Muthiah, Mark Dhinesh; Panaro, Fabrizio; Sanabria, Juan; Grothey, Axel; Moodley, Keymanthri; Chau, Ian; Chan, Albert C. Y.; Wang, Chih Chi; Menon, Krishna; Sapisochin, Gonzalo; Hagness, Morten; Dueland, Svein; Line, Pal-Dag; Adam, Rene Share Save Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patientsPuccini, Alberto; Seeber, Andreas; Xiu, Joanne; Goldberg, Richard M.; Soldato, Davide; Grothey, Axel; Shields, Anthony F.; Salem, Mohamed E.; Battaglin, Francesca; Berger, Martin D.; El-Deiry, Wafik S.; Tokunaga, Ryuma; Naseem, Madiha; Zhang, Wu; Arora, Sukeshi Patel; Khushman, Moh'd M.; Hall, Michael J.; Philip, Philip A.; Marshall, John L.; Korn, W. Michael; Lenz, Heinz-Josef Share Save Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer TrialsYin, Jun; Salem, Mohamed E.; Dixon, Jesse G.; Jin, Zhaohui; Cohen, Romain; DeGramont, Aimery; Van Cutsem, Eric; Taieb, Julien; Alberts, Steven R.; Wolmark, Norman; Schmoll, Hans-Joachim; Saltz, Leonard B.; George, Thomas J.; Goldberg, Richard R. M.; Kerr, Rachel; Lonardi, Sara; Yoshino, Takayuki; Yothers, Greg; Grothey, Axel; Andre, Thierry; Shi, Qian Share Save Utilisation and predictors of genomic testing prior to firstline (1L) therapy in patients (pts) with metastatic colorectal cancer (mCRC)Lenz, H. J.; Weberpals, J.; Cremolini, C.; Grothey, A.; Leutgeb, B.; Mahrus, S.; Nimeiri, H.; Reyes-Rivera, I.; Seligmann, J.; Tabernero, J.; Tejpar, S.; Yoshino, T.; Stintzing, S. Share Save Exploratory biomarker analysis of DESTINY-CRC01, a phase II, multicenter, open-label study of trastuzumab deruxtecan (T-DXd, DS-8201) in patients (pts) with HER2-expressing metastatic colorectal cancer (mCRC)Siena, S.; Raghav, K.; Masuishi, T.; Yamaguchi, K.; Nishina, T.; Elez, E.; Rodriguez, J.; Chau, I.; Di Bartolomeo, M.; Kawakami, H.; Suto, F.; Kobayashi, K.; Koga, M.; Inaki, K.; Kuwahara, Y.; Takehara, I.; Grothey, A.; Yoshino, T. Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
